-
Signature
-
/s/ Shelley Thunen, as Attorney-in-Fact
-
Issuer symbol
-
RXST
-
Transactions as of
-
09 Feb 2024
-
Net transactions value
-
-$309,340
-
Form type
-
4
-
Filing time
-
12 Feb 2024, 18:02:25 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
RXST |
Common Stock |
Options Exercise |
$101,398 |
+5,365 |
+20% |
$18.90 |
31,840 |
09 Feb 2024 |
Direct |
|
| transaction |
RXST |
Common Stock |
Options Exercise |
$115,200 |
+5,000 |
+16% |
$23.04 |
36,840 |
09 Feb 2024 |
Direct |
|
| transaction |
RXST |
Common Stock |
Sale |
$270,939 |
-5,365 |
-15% |
$50.50 |
31,475 |
09 Feb 2024 |
Direct |
F1, F2 |
| transaction |
RXST |
Common Stock |
Sale |
$255,000 |
-5,000 |
-16% |
$51.00 |
26,475 |
09 Feb 2024 |
Direct |
F1 |
| holding |
RXST |
Common Stock |
|
|
|
|
|
1,372 |
09 Feb 2024 |
By spouse |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
RXST |
Stock Option (right to buy) |
Options Exercise |
$0 |
-5,365 |
-57% |
$0.000000 |
3,995 |
09 Feb 2024 |
Common Stock |
5,365 |
$18.90 |
Direct |
|
| transaction |
RXST |
Stock Option (right to buy) |
Options Exercise |
$0 |
-5,000 |
-17% |
$0.000000 |
25,000 |
09 Feb 2024 |
Common Stock |
5,000 |
$23.04 |
Direct |
|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: